×

Do you want to link to the external site and leave Amgen.ca?

You are now leaving Amgen Canada's website. Amgen Canada takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on the server or site.

×

Do you want to link to our other external sites and leave Amgen.ca?

You are now leaving Amgen Canada's website. Amgen Canada takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on the server or site.

Searching for the Answers Within

At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.

Amgen Canada applies science and innovation to help fight serious illness and dramatically improve people’s lives. With main operations located in Mississauga’s vibrant biomedical cluster, and a research facility in Burnaby, British Columbia, Amgen’s Canadian affiliate has been an important contributor to Canada’s biotechnology sector since 1991.

Amgen Canada serves patients throughout Canada by delivering vital medicines to them. In addition, Amgen contributes to the development of new therapies or new uses for existing medicines in partnership with many of Canada’s leading health care, academic, research, government and patient organizations. Today, tens of thousands of Canadians use Amgen medicines every year, and thousands more are enrolling in Amgen clinical studies to deliver the next generation of innovation.

Globally, Amgen is a leading human therapeutics company in the biotechnology industry. For more than 35 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine.

Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines.